The strategy ´New Heights´ outlines Columbus’ trajectory for 2024-2026. Over the next three years, we will leverage our strong foundation created with Focus23 and focus on investing in high-growth service areas, accompanied by an expansion into the Life Science industry. Our goal is to achieve an average revenue growth rate of 10% and to culminate with an EBITDA margin of 15% by the close of 2026.